Display options
Share it on

Immunome Res. 2006 May 23;2:3. doi: 10.1186/1745-7580-2-3.

PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing.

Immunome research

Guang Lan Zhang, Nikolai Petrovsky, Chee Keong Kwoh, J Thomas August, Vladimir Brusic

Affiliations

  1. Institute for Infocomm Research, 21 Heng Mui Keng Terrace, 119613, Singapore. [email protected]

PMID: 16719926 PMCID: PMC1524936 DOI: 10.1186/1745-7580-2-3

Abstract

BACKGROUND: The transporter associated with antigen processing (TAP) is a critical component of the major histocompatibility complex (MHC) class I antigen processing and presentation pathway. TAP transports antigenic peptides into the endoplasmic reticulum where it loads them into the binding groove of MHC class I molecules. Because peptides must first be transported by TAP in order to be presented on MHC class I, TAP binding preferences should impact significantly on T-cell epitope selection.

DESCRIPTION: PRED(TAP) is a computational system that predicts peptide binding to human TAP. It uses artificial neural networks and hidden Markov models as predictive engines. Extensive testing was performed to valid the prediction models. The results showed that PRED(TAP) was both sensitive and specific and had good predictive ability (area under the receiver operating characteristic curve Aroc>0.85).

CONCLUSION: PRED(TAP) can be integrated with prediction systems for MHC class I binding peptides for improved performance of in silico prediction of T-cell epitopes. PRED(TAP) is available for public use at [1].

References

  1. Clin Exp Immunol. 2000 Aug;121(2):173-8 - PubMed
  2. J Immunol. 1996 Mar 15;156(6):2186-95 - PubMed
  3. Methods. 2004 Dec;34(4):429-35 - PubMed
  4. Immunol Cell Biol. 2002 Jun;80(3):280-5 - PubMed
  5. Protein Sci. 2005 Aug;14(8):2132-40 - PubMed
  6. J Immunol. 1998 Jul 15;161(2):617-24 - PubMed
  7. Immunol Rev. 2005 Oct;207:145-57 - PubMed
  8. Expert Rev Clin Immunol. 2005 May;1(1):145-57 - PubMed
  9. J Immunol. 2002 Nov 15;169(10):5744-53 - PubMed
  10. Science. 1988 Jun 3;240(4857):1285-93 - PubMed
  11. J Immunol. 1995 Feb 1;154(3):1273-9 - PubMed
  12. Protein Sci. 2004 Mar;13(3):596-607 - PubMed
  13. Methods. 2004 Dec;34(4):436-43 - PubMed
  14. Immunol Rev. 2005 Oct;207:19-30 - PubMed
  15. J Exp Med. 1995 Dec 1;182(6):1883-95 - PubMed
  16. Immunol Rev. 2005 Oct;207:42-59 - PubMed
  17. QJM. 2005 Oct;98(10):719-27 - PubMed
  18. J Immunol. 1996 May 15;156(10):3755-64 - PubMed
  19. BMC Bioinformatics. 2006;7:131 - PubMed
  20. In Silico Biol. 1999;1(2):109-21 - PubMed
  21. J Immunol. 2004 Dec 1;173(11):6813-9 - PubMed
  22. J Immunol. 1994 Apr 15;152(8):3904-12 - PubMed
  23. J Immunol. 2003 Aug 15;171(4):1741-9 - PubMed
  24. Cell Mol Life Sci. 2005 May;62(9):1025-37 - PubMed
  25. Immunol Rev. 2005 Oct;207:60-76 - PubMed
  26. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6047-57 - PubMed
  27. J Exp Med. 2001 Oct 15;194(8):1053-68 - PubMed
  28. Eur J Immunol. 2005 Aug;35(8):2295-303 - PubMed
  29. BMC Bioinformatics. 2005;6:132 - PubMed
  30. Biochim Biophys Acta. 1999 Dec 6;1461(2):405-19 - PubMed
  31. FEBS Lett. 2006 Feb 13;580(4):1156-63 - PubMed

Publication Types

Grant support